Bulk dispensing in Africa: The reality and the concerns
Download
Report
Transcript Bulk dispensing in Africa: The reality and the concerns
Bulk dispensing in Africa: The reality
and the concerns
Stand in presentation
Alex Dodoo, President, Pharmaceutical Society of
Ghana
The Reality
Dispensing from bulk is the norm rather than the exception
for products in sub-Saharan Africa
For products like
Tablets
Capsules
Syrups
Suspensions
Creams and ointments especially in hospitals
The Reality
Even smaller packed products are dispensed from bulk
especially when they are expensive
Products for erectile dysfunction
Products for prostate cancer etc
Products like glyceryl trinitrate have been known to be
dispensed from bulk!
Exceptions
Inhalers, Injections, Some creams, ointments, lotions
Features of the Dispensing Landscape
in Africa
Very poor labelling of dispensed medicines
Poor patient counselling
Dodoo, A.N.O et al., Rational drug use in Korle-Bu: A five day baseline survey of drug use indicators at the Korle-Bu
Teaching Hospital, Accra, Ghana. Ghana Pharm. J. 2001, 24(3):14-16
Presence of counterfeit and sub-standard products in the pharmaceutical
supply chain
Dispensing by non-pharmacists and lower qualified personnel
Absence of tablet counters/trays
Counting by hand
Counting cytotoxics as well as other products using “plastic spoons” etc
Dispensing liquid in bulk
Bottles to be brought by parents
No medicine spoons
Illiteracy as well as presence of products with labels in other languages apart
from the official national languages
Implications
Patient safety
Errors
Counterfeit
Expired products
Sub-standard products
No labelling so difficult to check
No counselling and no knowledge by patients
Implications
Adherence
Lack of knowledge by patients
Difficulty of patients to know what to take
Patients not returning to pharmacy to buy “remainder of expensive
medicines” especially if they “feel” better
Product integrity
Packaging in plastic and paper “envelopes”
Effect of moisture, humidity etc
Regulatory challenge
Checking adherence to existing regulations on dispensing etc
Impossible to sue for negligence
Opportunities
Pharmaceutical industry
To ensure that their products are appropriately packaged to
reduce counterfeiting and environmental problems
National governments, especially where there is a national
health insurance service
NHIS packs etc
Pharmacy and Medicine Regulators
Insistence on patient packs as well as patient information leaflets
as well as proper labelling of all products
Reduction of costs of registering various packs of the same
products
Other necessary regulatory measures